Abingworth Bioventures VII LP — Form D/A
Abingworth Bioventures VII LP of LONDON, X0, a pooled investment fund, filed a Form D amendment with the SEC on 2016-11-16. The offering totals $400.0M, of which $115.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2016-11-16
- Form: D/A
- Accession: 0001688313-16-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $400.0M
- Amount sold: $115.5M
- Remaining: $284.5M
- Investors: 9
- Date of first sale: 2016-11-07
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-274482
Issuer
- Name: Abingworth Bioventures VII LP
- CIK: 0001688313
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2016
- Address: PRINCES HOUSE, LONDON, X0, SW1Y 6DN
- Phone: 44 207 534 1500
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Shelley Chu | Promoter | Lexington, MA |
| Kurt von Emster | Executive Officer | Redwood City, CA |
| John Heard | Executive Officer | London, X0 |
| James Abell | Executive Officer | Boston, MA |
| Vincent Miles | Promoter | Belmont, MA |
| N/A ABINGWORTH MANAGEMENT INC | Promoter | MENLO PARK, CA |
| GENGHIS LLOYD-HARRIS | Executive Officer | LONDON, X0 |
| DAVID LEATHERS | Director | LONDON, X0 |
| N/A ABINGWORTH LLP | Promoter | LONDON, X0 |
| STEPHEN BUNTING | Executive Officer | LONDON, X0 |
| TIMOTHY HAINES | Executive Officer | LONDON, X0 |
| KENNETH HAAS | Promoter | MENLO PARK, CA |
| N/A ABINGWORTH BIOVENTURES VII GP LP | Promoter | EDINBURGH, X0 |
| MICHAEL BIGHAM | Promoter | BOSTON, MA |
Other filings by this issuer (2)
More